Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Clinical trial NCT06475989 · RECRUITING

Trial details

NCT number: NCT06475989
Sponsor: ECOG-ACRIN Cancer Research Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Differentiated Thyroid Gland Carcinoma

Start date: 2024-08-22
Primary completion: 2030-09-30
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.